Skip to content

PRESSURE BIOSCIENCES, INC.: 10-Q filed 2015-08-14

What PRESSURE BIOSCIENCES, INC. reported in its quarterly report filed 2015-08-14 (fiscal Q2 2015): 32 published measures, 82 facts as tagged in accession 0001493152-15-003752.

This filing

Form
10-Q (quarterly report)
Filed
2015-08-14
Fiscal period
fiscal Q2 2015
Accession
0001493152-15-003752 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PRESSURE BIOSCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-06-301,361,386USD
At 2014-12-311,744,132USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2015-06-305,690,386USD
At 2014-12-313,803,863USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-06-30-4,329,000USD
At 2014-12-31-2,059,731USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-06-3038,175USD
At 2014-12-31473,948USD
At 2014-06-309,369USD
At 2013-12-3131,417USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-1,386,241USD91
2015-01-01 to 2015-06-30-2,772,232USD181
2014-04-01 to 2014-06-30-603,187USD91
2014-01-01 to 2014-06-30-2,362,842USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2015-01-01 to 2015-06-30-1,850,785USD181
2014-01-01 to 2014-06-30-1,756,476USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-01-01 to 2015-06-306,662USD181
2014-01-01 to 2014-06-307,139USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2015-01-01 to 2015-06-301,421,674USD181
2014-01-01 to 2014-06-301,741,567USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2015-01-01 to 2015-06-30-6,662USD181
2014-01-01 to 2014-06-30-7,139USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-06-30-34,914,425USD
At 2014-12-31-32,118,714USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-06-3030,500USD
At 2014-12-3136,025USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-01-01 to 2015-06-30110,506USD181
2014-01-01 to 2014-06-3040,384USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-1,063,889USD91
2015-01-01 to 2015-06-30-1,938,708USD181
2014-04-01 to 2014-06-30-846,757USD91
2014-01-01 to 2014-06-30-1,629,123USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-06-301,330,886USD
At 2014-12-311,708,107USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2015-04-01 to 2015-06-30640,691USD91
2015-01-01 to 2015-06-301,246,276USD181
2015-06-22 to 2015-06-2410,000USD3
2014-04-01 to 2014-06-30341,649USD91
2014-01-01 to 2014-06-30478,313USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-06-305,690,386USD
At 2014-12-313,774,886USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2015-06-30979,479USD
At 2014-12-311,035,781USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2015-06-30349,958USD
At 2014-12-31272,022USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-04-01 to 2015-06-301,476,993USD91
2015-01-01 to 2015-06-302,791,946USD181
2014-04-01 to 2014-06-301,154,221USD91
2014-01-01 to 2014-06-302,340,734USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2015-06-30783,891USD
At 2014-12-31850,552USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-04-01 to 2015-06-30291,402USD91
2015-01-01 to 2015-06-30523,325USD181
2014-04-01 to 2014-06-30253,238USD91
2014-01-01 to 2014-06-30484,326USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-06-3019,939,131shares
At 2014-12-3118,673,390shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-06-3025,037,861USD
At 2014-12-3124,617,564USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2015-06-30803,789USD
At 2014-12-31719,432USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2015-06-30151,481USD
At 2014-12-31104,204USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-1,393,052USD91
2015-01-01 to 2015-06-30-2,795,711USD181
2014-04-01 to 2014-06-30-720,789USD91
2014-01-01 to 2014-06-30-3,805,497USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-30810,220USD91
2015-01-01 to 2015-06-301,536,244USD181
2014-04-01 to 2014-06-30570,456USD91
2014-01-01 to 2014-06-301,176,935USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-322,352USD91
2015-01-01 to 2015-06-30-833,524USD181
2014-04-01 to 2014-06-30243,570USD91
2014-01-01 to 2014-06-30-733,719USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2014-01-01 to 2014-06-30149,165USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-3077,936USD181
2014-01-01 to 2014-06-3043,090USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-30-66,661USD181
2014-01-01 to 2014-06-30116,543USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-30-56,302USD181
2014-01-01 to 2014-06-3059,309USD181

Inspect the source

Entity
PRESSURE BIOSCIENCES, INC. / CIK 0000830656
Captured
2026-09-21T17:17:15.791Z
SEC response SHA-256
9f53d6670ff4d2eff56cabbc6920a9205a8540e6e5042ac9d3ad7d038501b96e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000830656.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))